2004•European Journal of Clinical PharmacologyOpen access

Oral administration of a low dose of midazolam (75�?g) as an in vivo probe for CYP3A activity

Chin B. Eap, Thierry Buclin, Gianni Cucchia, Daniele Zullino, Elisabeth Hustert, Gabriela Bleiber, KerryPowell Golay, Anne-Catherine Aubert, Pierre Baumann, Amalio Telenti, Reinhold Kerb

Open full text 95 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 95 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Midazolam, CYP3A, Oral administration, Ketoconazole, Pharmacology, In vivo, Chemistry, Pharmacokinetics

Back to paper search Browse research topics Original source

Oral administration of a low dose of midazolam (75�?g) as an in vivo probe for CYP3A activity — Research Paper | ScholarLens